Wearable sensors assist in developing safer and better home dialysis – HUS and VTT start testing with patients

ESPOO, Finland, Jan. 8, 2026 /PRNewswire/ -- HUS Helsinki University Hospital and VTT are starting a field test of wearable sensors to develop home dialysis. A total of 36 volunteer patients will use the sensors that enable monitoring of treatment effectivity. Making home dialysis safer and better would improve life quality and save society millions of euros annually.

Currently, dialysis treatment of the kidneys typically requires three weekly hospital visits. It is expensive to society and burdensome for patients, lowering the quality of life and treatment outcomes.

Home dialysis is preferable and much cheaper, but its availability is still limited. Also, because patients typically visit the hospital for follow-up every second or third month, there is a lack of information between visits. Therefore, Helsinki University Hospital (HUS), together with VTT as a technology partner, is starting a field test to monitor home dialysis patients.

“If we could increase home treatment and have a better feeling of its safety, we could improve outcomes and raise the life quality of patients. The whole society could save about eleven million euros per year,” says Virpi Rauta, Lead of CleverHealth Network Ecosystem at Helsinki University Hospital.

Sign up for Blog Updates